Insider Trading & Ownership - COLUMN GROUP L P

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for COLUMN GROUP L P
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-11-15
Purchase
2023-11-17
4:33 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
22,631$0.6852$15,50721,743,413
(Indirect
Direct)
View
2023-11-15
Purchase
2023-11-17
4:30 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
22,631$0.6852$15,50721,743,413
(Indirect
Direct)
View
2023-11-15
Purchase
2023-11-17
4:28 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
22,631$0.6852$15,50721,743,413
(Indirect
Direct)
View
2023-01-30
Purchase
2023-02-01
4:50 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
184,272$4.9986$921,11021,720,782
(Indirect
Direct)
View
2023-01-30
Purchase
2023-02-01
4:31 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
184,272$4.9986$921,11021,720,782
(Indirect
Direct)
View
2023-01-30
Purchase
2023-02-01
4:29 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
184,272$4.9986$921,11021,720,782
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:38 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
9,900$4.9994$49,49421,536,510
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:35 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
9,900$4.9994$49,49421,536,510
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:31 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
9,900$4.9994$49,49421,536,510
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:25 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
38,139$4.9976$190,60321,526,610
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:22 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
38,139$4.9976$190,60321,526,610
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:19 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
38,139$4.9976$190,60321,526,610
(Indirect
Direct)
View
2023-01-12
Purchase
2023-01-17
4:36 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
5,378$4.9466$26,60321,488,471
(Indirect
Direct)
View
2023-01-12
Purchase
2023-01-17
4:34 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
5,378$4.9466$26,60321,488,471
(Indirect
Direct)
View
2023-01-12
Purchase
2023-01-17
4:32 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
5,378$4.9466$26,60321,488,471
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:40 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
309,070$4.7865$1,479,35921,483,093
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:37 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
309,070$4.7865$1,479,35921,483,093
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:35 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
309,070$4.7865$1,479,35921,483,093
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:31 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
300$4.9767$1,49321,174,023
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:29 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
300$4.9767$1,49321,174,023
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:28 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
300$4.9767$1,49321,174,023
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:21 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
40,327$4.9988$201,58821,173,723
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:17 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
40,327$4.9988$201,58821,173,723
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:14 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
40,327$4.9988$201,58821,173,723
(Indirect
Direct)
View
2022-11-03
Purchase
2022-11-07
4:30 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
139,148$4.9187$684,42721,133,396
(Indirect
Direct)
View
2022-11-03
Purchase
2022-11-07
4:20 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
139,148$4.9187$684,42721,133,396
(Indirect
Direct)
View
2022-11-03
Purchase
2022-11-07
4:17 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
139,148$4.9187$684,42721,133,396
(Indirect
Direct)
View
2022-10-27
Purchase
2022-10-31
5:20 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
76,877$4.8602$373,63820,994,248
(Indirect
Direct)
View
2022-10-27
Purchase
2022-10-31
5:19 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
76,877$4.8602$373,63820,994,248
(Indirect
Direct)
View
2022-10-27
Purchase
2022-10-31
5:17 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
76,877$4.8602$373,63820,994,248
(Indirect
Direct)
View
2022-10-25
Purchase
2022-10-27
6:58 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
TCG Opportunity III GP LLC
Director
10% Owner
123,820$4.8088$595,42820,917,371
(Indirect
Direct)
View
2022-10-25
Purchase
2022-10-27
6:55 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
123,820$4.8088$595,42820,917,371
(Indirect
Direct)
View
2022-10-25
Purchase
2022-10-27
6:50 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
123,820$4.8088$595,42820,917,371
(Indirect
Direct)
View
2022-06-09
Purchase
2022-06-13
5:05 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
984,161$13.5$13,286,17418,143,374
(Indirect
Direct)
View
2022-06-09
Purchase
2022-06-13
4:58 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
984,161$13.5$13,286,17418,143,374
(Indirect
Direct)
View
2022-06-02
Purchase
2022-06-06
4:44 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
34,200$13.03$445,73918,110,897
(Indirect
Direct)
View
2022-06-02
Purchase
2022-06-06
4:43 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
34,200$13.03$445,73918,110,897
(Indirect
Direct)
View
2022-05-31
Purchase
2022-06-02
4:28 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
153,806$13.46$2,069,66718,109,768
(Indirect
Direct)
View
2022-05-31
Purchase
2022-06-02
4:26 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
153,806$13.46$2,069,66718,109,768
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-05
Disposition
2024-04-08
8:03 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
20,344,505$02,000
(Indirect)
View
2024-04-05
Other
2024-04-08
8:03 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
1,000$02,000
(Indirect)
View
Goto 0, 1, 2, 3, Next